National Headlines

Insurance Journal | “Direct to Consumer Genetic Testing: Risks and Opportunities”

Click Here to Learn More About How Concierge Medicine Physicians Are Adopting Advanced Healthcare Testing Tools …

By Katharina Ó Cathaoir | April 14, 2017   

Accurate genetic testing stands to transform modern medicine by offering effective, personalized treatment. Last week, the U.S. Food and Drug Administration (FDA) authorized marketing of the first direct-to-consumer (DTC) genetic health risk (GHR) tests. Individuals in the U.S. can now purchase DTC tests and gain potentially useful information on their genetic predisposition to 10 diseases or conditions, such as late-onset Alzheimer’s or Parkinson’s disease.

RELATED STORY

Support For Use of Whole Genome Sequencing in Concierge Medicine

CONCLUSION  Genetic testing is certainly here to stay. Greater genetic awareness and information could encourage patient mobilization and demands for personalized medicine. 23andme is the world’s largest bio/databank and individuals are given the option to donate samples. So beyond individual information, research breakthroughs may be on the horizon should individuals choose to donate their samples for further study.

READ MORE …

SOURCE: http://www.insurancejournal.com/news/national/2017/04/14/447812.htm

Categories: National Headlines

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.